Historical record - last NADAC publication: 1/22/2014
Product Information
AMPICILLIN 1 GM VIAL is a generic product labeled by Eugia US LLC, priced at $4.3059 per EA under NDC 55150011310. Its NADAC has been published 56 times since Jan 22, 2014.
Strength
1 g/1
Manufacturer
Eugia US LLCNDC
55150011310
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
1/22/2014
Active Ingredients
AMPICILLIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065499On Market Since
2/1/2012
Pharmacological Classes
Price Statistics
The NADAC for AMPICILLIN 1 GM VIAL has been published 56 times since Jan 22, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3059 per EA |
|---|---|
| All-time high | $4.3059 (Feb 11, 2015) |
| All-time low | $4.3059 (Jan 22, 2014) |
| Median price | $4.3059 |
| Average price | $4.3059 |
| Largest weekly change | 0.0% (Jan 29, 2014) |
| Weeks tracked | 56 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Ampicillin Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AMPICILLIN 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for AMPICILLIN 1 GM VIAL, manufactured by Eugia US LLC, is $4.3059 per EA (NDC 55150011310), effective Feb 11, 2015.
How has the price of AMPICILLIN 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for AMPICILLIN 1 GM VIAL has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for AMPICILLIN 1 GM VIAL?
Since Jan 22, 2014, the NADAC for AMPICILLIN 1 GM VIAL has ranged from a low of $4.3059 (Jan 22, 2014) to a high of $4.3059 (Feb 11, 2015), with a median of $4.3059 per EA.
Are there cheaper alternatives to AMPICILLIN 1 GM VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMPICILLIN 1 GM VIAL, so no direct lower-cost alternative is listed.
Who manufactures AMPICILLIN 1 GM VIAL?
AMPICILLIN 1 GM VIAL (NDC 55150011310) is labeled by Eugia US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification